Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))

Long Mao; Namir Shaabani; Xiaoying Zhang; Can Jin; Wanhong Xu; Christopher Argent; Yulia Kushnareva; Colin Powers; Karen Stegman; Jia Liu; Hui Xie; Changxu Xu; Yimei Bao; Lijun Xu; Yuren Zhang; Haigang Yang; Shengdian Qian; Yong Hu; Jianping Shao; Can Zhang; Tingting Li; Yi Li; Na Liu; Zhenhao Lin; Shanbo Wang; Chao Wang; Wei Shen; Yuanlong Lin; Dan Shu; Zhenhong Zhu; Olivia Kotoi; Lisa Kerwin; Qing Han; Ludmila Chumakova; John Teijaro; Mike Royal; Mark Brunswick; Robert Allen; Henry Ji; Hongzhou Lu; Xiao Xu

doi:10.1016/j.medj.2024.01.013

Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M^pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))

Long Mao
, Namir Shaabani
, Xiaoying Zhang
, Can Jin
, Wanhong Xu
, Christopher Argent
, Yulia Kushnareva
, Colin Powers
, Karen Stegman
, Jia Liu
, Hui Xie
, Changxu Xu
, Yimei Bao
, Lijun Xu
, Yuren Zhang
, Haigang Yang
, Shengdian Qian
, Yong Hu
, Jianping Shao
, Can Zhang

Tingting Li, Yi Li, Na Liu, Zhenhao Lin, Shanbo Wang, Chao Wang, Wei Shen, Yuanlong Lin, Dan Shu, Zhenhong Zhu, Olivia Kotoi, Lisa Kerwin, Qing Han, Ludmila Chumakova, John Teijaro, Mike Royal, Mark Brunswick, Robert Allen, Henry Ji, Hongzhou Lu, Xiao Xu

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Abstract

(Med 5, 42–61.e1–e23; January 12, 2024) In our originally published article, we inadvertently omitted a value in the table of Figure 4A. The cell in column “2000 mg” and row “C_max (ng/mL)^a” contained only the standard deviation (± 5050), while the mean value (17800) was missing. The text within the cell has been corrected online from “± 5050” to “17800 ± 5050,” and the full revised figure appears below. The authors apologize for this error and any confusion it may have caused.

Original language	English
Pages (from-to)	169-171
Number of pages	3
Journal	Med
Volume	5
Issue number	2
DOIs	https://doi.org/10.1016/j.medj.2024.01.013
State	Published - 9 Feb 2024
Externally published	Yes

Access to Document

10.1016/j.medj.2024.01.013

Fingerprint

Dive into the research topics of 'Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M^pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))'. Together they form a unique fingerprint.

Cite this

Mao, L., Shaabani, N., Zhang, X., Jin, C., Xu, W., Argent, C., Kushnareva, Y., Powers, C., Stegman, K., Liu, J., Xie, H., Xu, C., Bao, Y., Xu, L., Zhang, Y., Yang, H., Qian, S., Hu, Y., Shao, J., ... Xu, X. (2024). Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M^pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004)). Med, 5(2), 169-171. https://doi.org/10.1016/j.medj.2024.01.013

@article{f36e6258da264f079b89c4f318dfd06e,

title = "Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42{\textendash}61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))",

abstract = "(Med 5, 42{\textendash}61.e1{\textendash}e23; January 12, 2024) In our originally published article, we inadvertently omitted a value in the table of Figure 4A. The cell in column {\textquotedblleft}2000 mg{\textquotedblright} and row {\textquotedblleft}Cmax (ng/mL)a{\textquotedblright} contained only the standard deviation (± 5050), while the mean value (17800) was missing. The text within the cell has been corrected online from {\textquotedblleft}± 5050{\textquotedblright} to {\textquotedblleft}17800 ± 5050,{\textquotedblright} and the full revised figure appears below. The authors apologize for this error and any confusion it may have caused.",

author = "Long Mao and Namir Shaabani and Xiaoying Zhang and Can Jin and Wanhong Xu and Christopher Argent and Yulia Kushnareva and Colin Powers and Karen Stegman and Jia Liu and Hui Xie and Changxu Xu and Yimei Bao and Lijun Xu and Yuren Zhang and Haigang Yang and Shengdian Qian and Yong Hu and Jianping Shao and Can Zhang and Tingting Li and Yi Li and Na Liu and Zhenhao Lin and Shanbo Wang and Chao Wang and Wei Shen and Yuanlong Lin and Dan Shu and Zhenhong Zhu and Olivia Kotoi and Lisa Kerwin and Qing Han and Ludmila Chumakova and John Teijaro and Mike Royal and Mark Brunswick and Robert Allen and Henry Ji and Hongzhou Lu and Xiao Xu",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s)",

year = "2024",

month = feb,

day = "9",

doi = "10.1016/j.medj.2024.01.013",

language = "English",

volume = "5",

pages = "169--171",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "2",

}

Mao, L, Shaabani, N, Zhang, X, Jin, C, Xu, W, Argent, C, Kushnareva, Y, Powers, C, Stegman, K, Liu, J, Xie, H, Xu, C, Bao, Y, Xu, L, Zhang, Y, Yang, H, Qian, S, Hu, Y, Shao, J, Zhang, C, Li, T, Li, Y, Liu, N, Lin, Z, Wang, S, Wang, C, Shen, W, Lin, Y, Shu, D, Zhu, Z, Kotoi, O, Kerwin, L, Han, Q, Chumakova, L, Teijaro, J, Royal, M, Brunswick, M, Allen, R, Ji, H, Lu, H & Xu, X 2024, 'Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M^pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))', Med, vol. 5, no. 2, pp. 169-171. https://doi.org/10.1016/j.medj.2024.01.013

Erratum: Olgotrelvir, a dual inhibitor of SARS-CoV-2 M^pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004)). / Mao, Long; Shaabani, Namir; Zhang, Xiaoying et al.
In: Med, Vol. 5, No. 2, 09.02.2024, p. 169-171.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (Med (2024) 5(1) (42–61.e23), (S2666634023004026), (10.1016/j.medj.2023.12.004))

AU - Mao, Long

AU - Shaabani, Namir

AU - Zhang, Xiaoying

AU - Jin, Can

AU - Xu, Wanhong

AU - Argent, Christopher

AU - Kushnareva, Yulia

AU - Powers, Colin

AU - Stegman, Karen

AU - Liu, Jia

AU - Xie, Hui

AU - Xu, Changxu

AU - Bao, Yimei

AU - Xu, Lijun

AU - Zhang, Yuren

AU - Yang, Haigang

AU - Qian, Shengdian

AU - Hu, Yong

AU - Shao, Jianping

AU - Zhang, Can

AU - Li, Tingting

AU - Li, Yi

AU - Liu, Na

AU - Lin, Zhenhao

AU - Wang, Shanbo

AU - Wang, Chao

AU - Shen, Wei

AU - Lin, Yuanlong

AU - Shu, Dan

AU - Zhu, Zhenhong

AU - Kotoi, Olivia

AU - Kerwin, Lisa

AU - Han, Qing

AU - Chumakova, Ludmila

AU - Teijaro, John

AU - Royal, Mike

AU - Brunswick, Mark

AU - Allen, Robert

AU - Ji, Henry

AU - Lu, Hongzhou

AU - Xu, Xiao

PY - 2024/2/9

Y1 - 2024/2/9

N2 - (Med 5, 42–61.e1–e23; January 12, 2024) In our originally published article, we inadvertently omitted a value in the table of Figure 4A. The cell in column “2000 mg” and row “Cmax (ng/mL)a” contained only the standard deviation (± 5050), while the mean value (17800) was missing. The text within the cell has been corrected online from “± 5050” to “17800 ± 5050,” and the full revised figure appears below. The authors apologize for this error and any confusion it may have caused.

AB - (Med 5, 42–61.e1–e23; January 12, 2024) In our originally published article, we inadvertently omitted a value in the table of Figure 4A. The cell in column “2000 mg” and row “Cmax (ng/mL)a” contained only the standard deviation (± 5050), while the mean value (17800) was missing. The text within the cell has been corrected online from “± 5050” to “17800 ± 5050,” and the full revised figure appears below. The authors apologize for this error and any confusion it may have caused.

UR - https://www.scopus.com/pages/publications/85184143521

U2 - 10.1016/j.medj.2024.01.013

DO - 10.1016/j.medj.2024.01.013

M3 - Comment/debate

C2 - 38340710

AN - SCOPUS:85184143521

SN - 2666-6359

VL - 5

SP - 169

EP - 171

JO - Med

JF - Med

IS - 2

ER -